Company Update – Abbott Laboratories (NYSE:ABT) – Abbott Laboratories Raised Its Dividend 57%, But Is It A Buy Right Now?

[at Seeking Alpha] – The last time I wrote about Abbott Laboratories ( ABT ) I did not buy any more shares stating that I thought the stock had moved up too far . . . → Read More: Company Update – Abbott Laboratories (NYSE:ABT) – Abbott Laboratories Raised Its Dividend 57%, But Is It A Buy Right Now? Similar posts: Celgene Corporation (NASDAQ:CELG) ~ Celgene price target raised to $186 from $171 at Cantor Defensive dividend stocks to look at Boeing’s Double Top: Will the company continue to soar?